US Patent 9801934 Parenteral norovirus vaccine formulations
Patent 9801934 was granted and assigned to Takeda (company) on October, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+302 characters)
Article
Patent abstract
The present invention relates to single dose parenteral vaccine compositions comprising mixtures of monovalent Norovirus virus-like particles. Methods of conferring protective immunity against Norovirus infections in a human subject by administering such compositions are also disclosed.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Charles Richardson0
Thomas R. Foubert0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09801934 Parenteral norovirus vaccine formulations US Patent 9801934 Parenteral norovirus vaccine formulations
Infobox
Patent Number
098019340
Patent Number
98019340
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
098019340
Date of Patent
October 31, 2017
0Patent Application Number
138404030
Date Filed
March 15, 2013
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09801934 Parenteral norovirus vaccine formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09801934
Date of patent
October 31, 2017
Patent application number
13840403
Date Filed
March 15, 2013
Patent primary examiner
Find more entities like US Patent 9801934 Parenteral norovirus vaccine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
